Advisory Board January 14, 2026

GLP-1 drugs can help patients lose a significant amount of weight, but many regain this weight after they stop taking the medication. As this issue becomes more common, researchers are exploring ways to help patients maintain weight loss in the long term.

Weight rebounds after stopping GLP-1s

According to a new study published in The BMJ, people who stopped taking weight management drugs, including GLP-1s, typically regained the weight they lost and reversed their cardiometabolic improvements within two years.

Researchers analyzed data from 37 studies with 9,341 participants, which included randomized controlled trials, non-randomized trials, and observation analyses. The studies had an average treatment duration of 39 weeks and an average follow-up period of 32 weeks. The treatments included GLP-1s...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Provider
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat
Biotech investor Cormorant secures $150M for another SPAC deal
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety

Share Article